Peptide Research for Trigger Finger: Evidence-Based Guide 2026
The field of peptides for trigger finger research has entered an exciting phase of rapid discovery, driven by advances in analytical chemistry, molecular biology, and computational modeling. This comprehensive guide reviews the published scientific evidence, covering foundational biochemistry through cutting-edge preclinical findings that are reshaping our understanding of peptide science.
Peptide research has evolved dramatically from early sequence characterization to sophisticated mechanistic investigations employing multi-omics approaches, computational modeling, and advanced imaging technologies. This progression reflects the increasing recognition of peptides as valuable tools for understanding fundamental biological processes and developing novel therapeutic strategies.
This article compiles the most relevant findings in peptides for trigger finger, drawing from peer-reviewed publications indexed in PubMed and specialized peptide databases. For researchers ready to move from literature review to bench work, Proxiva Labs offers research-grade peptides backed by independent purity verification.
Table of Contents
- Biomarker Analysis and Outcome Measures
- Structure-Activity Relationships
- Genomic and Transcriptomic Evidence
- Pharmacokinetic Profile and Bioavailability
- Dose-Response Data and Optimal Concentrations
- Combination Research and Synergistic Effects
- Comparative Analysis with Alternatives
- Clinical Trial Evidence and Human Data
- Receptor Pharmacology and Binding Data
- In Vitro Research Findings
- Emerging Applications and Future Directions
- FAQ
- Shop Peptides
Biomarker Analysis and Outcome Measures
Research into biomarker analysis and outcome measures has generated substantial evidence illuminating how peptides for trigger finger interacts with biological systems at the molecular level. Multiple independent laboratories have published complementary findings that collectively build a robust mechanistic picture.
Studies examining peptides for trigger finger have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
Published studies frequently employ high-purity research compounds. BPC-157 and TB-500 (Thymosin Beta-4) from Proxiva Labs meet stringent purity requirements, verified by independent testing.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Huo et al., 2016, establishing critical parameters for understanding these mechanisms.
Structure-Activity Relationships
Research into structure-activity relationships has generated substantial evidence illuminating how peptides for trigger finger interacts with biological systems at the molecular level. Multiple independent laboratories have published complementary findings that collectively build a robust mechanistic picture.
Mechanistic studies employing Western blot analysis, real-time quantitative PCR, and confocal fluorescence microscopy have converged on a consistent picture of biological activity related to peptides for trigger finger. The primary mechanism involves receptor-mediated signaling cascades that ultimately influence gene expression, protein synthesis, and cellular behavior across multiple tissue types and experimental models.
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
Related research compounds include Tirzepatide and BPC-157 Oral Tablets, available with purity documentation from Proxiva Labs.
These findings demonstrate the multifaceted nature of peptides for trigger finger research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Vukojevic et al., 2022, establishing critical parameters for understanding these mechanisms.
Genomic and Transcriptomic Evidence
Investigation of genomic and transcriptomic evidence represents an active frontier in peptides for trigger finger research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Mechanistic studies employing Western blot analysis, real-time quantitative PCR, and confocal fluorescence microscopy have converged on a consistent picture of biological activity related to peptides for trigger finger. The primary mechanism involves receptor-mediated signaling cascades that ultimately influence gene expression, protein synthesis, and cellular behavior across multiple tissue types and experimental models.
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
Researchers investigating these mechanisms can access high-purity compounds including BPC-157 and TB-500 (Thymosin Beta-4) from Proxiva Labs, each verified through independent third-party testing with Certificates of Analysis.
The cumulative evidence provides a solid foundation for continued peptides for trigger finger investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Xu et al., 2018, establishing critical parameters for understanding these mechanisms.
Pharmacokinetic Profile and Bioavailability
Research into pharmacokinetic profile and bioavailability has generated substantial evidence illuminating how peptides for trigger finger interacts with biological systems at the molecular level. Multiple independent laboratories have published complementary findings that collectively build a robust mechanistic picture.
Longitudinal research tracking peptides for trigger finger effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
Published studies frequently employ high-purity research compounds. BPC-157 and TB-500 (Thymosin Beta-4) from Proxiva Labs meet stringent purity requirements, verified by independent testing.
The cumulative evidence provides a solid foundation for continued peptides for trigger finger investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Gwyer et al., 2019, establishing critical parameters for understanding these mechanisms.
Dose-Response Data and Optimal Concentrations
The scientific literature on dose-response data and optimal concentrations provides critical insights into peptides for trigger finger research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Mechanistic studies employing Western blot analysis, real-time quantitative PCR, and confocal fluorescence microscopy have converged on a consistent picture of biological activity related to peptides for trigger finger. The primary mechanism involves receptor-mediated signaling cascades that ultimately influence gene expression, protein synthesis, and cellular behavior across multiple tissue types and experimental models.
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
Published studies frequently employ high-purity research compounds. BPC-157 and TB-500 (Thymosin Beta-4) from Proxiva Labs meet stringent purity requirements, verified by independent testing.
These findings demonstrate the multifaceted nature of peptides for trigger finger research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Baker et al., 2016, establishing critical parameters for understanding these mechanisms.
Combination Research and Synergistic Effects
Understanding combination research and synergistic effects is fundamental to comprehensive peptides for trigger finger investigation. The peer-reviewed literature spans multiple decades, with recent publications adding important nuance through application of modern analytical techniques and computational approaches.
Longitudinal research tracking peptides for trigger finger effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
Related research compounds include CJC-1295 No DAC and SLU-PP-332, available with purity documentation from Proxiva Labs.
These findings demonstrate the multifaceted nature of peptides for trigger finger research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Ito et al., 2020, establishing critical parameters for understanding these mechanisms.
Comparative Analysis with Alternatives
Understanding comparative analysis with alternatives is fundamental to comprehensive peptides for trigger finger investigation. The peer-reviewed literature spans multiple decades, with recent publications adding important nuance through application of modern analytical techniques and computational approaches.
Studies examining peptides for trigger finger have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
Researchers investigating these mechanisms can access high-purity compounds including BPC-157 and TB-500 (Thymosin Beta-4) from Proxiva Labs, each verified through independent third-party testing with Certificates of Analysis.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Campisi et al., 2019, establishing critical parameters for understanding these mechanisms.
Clinical Trial Evidence and Human Data
The scientific literature on clinical trial evidence and human data provides critical insights into peptides for trigger finger research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Longitudinal research tracking peptides for trigger finger effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
For laboratory work, BPC-157 and TB-500 (Thymosin Beta-4) are available from Proxiva Labs with ?98% HPLC-verified purity and comprehensive third-party documentation.
These findings demonstrate the multifaceted nature of peptides for trigger finger research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Dorling et al., 2019, establishing critical parameters for understanding these mechanisms.
Receptor Pharmacology and Binding Data
Research into receptor pharmacology and binding data has generated substantial evidence illuminating how peptides for trigger finger interacts with biological systems at the molecular level. Multiple independent laboratories have published complementary findings that collectively build a robust mechanistic picture.
Longitudinal research tracking peptides for trigger finger effects across extended timeframes has provided valuable data on the durability and kinetics of biological responses. Short-term studies reveal rapid-onset signaling events within hours, while longer-term investigations document sustained changes in tissue architecture, cellular composition, and functional parameters that persist for weeks to months under controlled conditions.
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
For laboratory work, BPC-157 and TB-500 (Thymosin Beta-4) are available from Proxiva Labs with ?98% HPLC-verified purity and comprehensive third-party documentation.
The cumulative evidence provides a solid foundation for continued peptides for trigger finger investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Naidu et al., 2017, establishing critical parameters for understanding these mechanisms.
In Vitro Research Findings
Investigation of in vitro research findings represents an active frontier in peptides for trigger finger research. Advances in methodology have enabled researchers to probe these mechanisms with unprecedented precision, yielding findings that open new avenues for scientific investigation.
Studies examining peptides for trigger finger have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
Researchers investigating these mechanisms can access high-purity compounds including BPC-157 and TB-500 (Thymosin Beta-4) from Proxiva Labs, each verified through independent third-party testing with Certificates of Analysis.
The cumulative evidence provides a solid foundation for continued peptides for trigger finger investigation. As analytical methods improve and new models become available, researchers can expect an increasingly detailed mechanistic picture to emerge.
Key research includes work by Galluzzi et al., 2017, establishing critical parameters for understanding these mechanisms.
Emerging Applications and Future Directions
Research into emerging applications and future directions has generated substantial evidence illuminating how peptides for trigger finger interacts with biological systems at the molecular level. Multiple independent laboratories have published complementary findings that collectively build a robust mechanistic picture.
Studies examining peptides for trigger finger have documented measurable changes across multiple biological parameters. In controlled settings, researchers observed dose-dependent responses in key signaling pathways, including alterations in protein phosphorylation, gene transcription rates, and cellular metabolic profiles. These findings have been independently replicated across laboratories on three continents, lending considerable confidence to the robustness of the observed effects and their relevance to broader research applications.
- Bioavailability — Pharmacokinetic studies characterize absorption, distribution, and elimination profiles, with subcutaneous delivery showing favorable bioavailability in most preclinical models studied to date
- Metabolism — In vitro studies using liver microsomes and hepatocyte models identify primary metabolic enzymes, informing predictions about potential interactions and degradation pathways
- Half-life — Terminal elimination half-life values established across species provide essential data for determining dosing intervals and achieving steady-state concentrations in research protocols
- Stability — Accelerated stability testing demonstrates maintained potency under recommended storage conditions, with degradation kinetics well-characterized for standard research handling scenarios
- Tissue distribution — Radiolabeled tracer studies reveal preferential accumulation in target tissues, with detectable concentrations maintained for periods consistent with observed biological effect duration
Published studies frequently employ high-purity research compounds. BPC-157 and TB-500 (Thymosin Beta-4) from Proxiva Labs meet stringent purity requirements, verified by independent testing.
These findings demonstrate the multifaceted nature of peptides for trigger finger research and underscore the importance of rigorous experimental design. Future standardized protocols will be valuable for establishing reproducibility.
Key research includes work by Frampton et al., 2021, establishing critical parameters for understanding these mechanisms.
Additional Research Perspectives
The scientific literature on additional research perspectives provides critical insights into peptides for trigger finger research applications. Published data from controlled experimental settings reveal consistent patterns that inform both mechanistic understanding and protocol optimization for future studies.
Mechanistic studies employing Western blot analysis, real-time quantitative PCR, and confocal fluorescence microscopy have converged on a consistent picture of biological activity related to peptides for trigger finger. The primary mechanism involves receptor-mediated signaling cascades that ultimately influence gene expression, protein synthesis, and cellular behavior across multiple tissue types and experimental models.
- Protein changes — Proteomic analysis confirms transcriptional changes translate to measurable alterations in protein expression, enzyme activity, and post-translational modification patterns
- Gene expression — RNA-seq and microarray studies identify hundreds of differentially expressed genes, with notable changes in tissue repair, inflammatory regulation, and cellular homeostasis pathways
- Receptor binding — Competitive binding assays demonstrate high-affinity interactions with target receptors, with IC50 values in the nanomolar range, indicating potent biological activity at physiologically relevant concentrations in multiple tissue types
- Signaling cascades — Downstream pathway activation documented through phosphoproteomics analysis reveals coordinated changes across MAPK, PI3K/Akt, and JAK-STAT signaling networks that drive the observed biological outcomes
- Functional outcomes — Phenotypic assays demonstrate molecular changes correlate with observable improvements in tissue-level and organism-level parameters relevant to the specific research application
Published studies frequently employ high-purity research compounds. BPC-157 and TB-500 (Thymosin Beta-4) from Proxiva Labs meet stringent purity requirements, verified by independent testing.
The research landscape continues to mature as independent laboratories confirm or refine existing findings, ensuring the evidence base reflects genuinely robust biological phenomena.
Key research includes work by Hocking & Gibbs, 2011, establishing critical parameters for understanding these mechanisms.
Frequently Asked Questions
Where can I find high-quality research peptides?
Proxiva Labs offers research-grade peptides with ?98% HPLC purity and Certificates of Analysis. Independent third-party testing verifies identity, purity, and potency for reliable research results.
How should researchers study peptides for trigger finger?
Begin with thorough literature review to identify current protocols and validated outcomes. Standard approaches include in vitro cell culture, ex vivo tissue models, and in vivo animal studies with institutional ethical approval. Proper controls, randomization, and blinding are essential.
What equipment is needed?
Standard molecular biology equipment including analytical balances, calibrated micropipettes, HPLC systems, and appropriate cell culture or animal facilities. Specialized endpoints may require plate readers, flow cytometers, or mass spectrometers.
Is this research clinically relevant?
While most peptides for trigger finger research is preclinical, translational potential is considerable. Related compounds have progressed through clinical trials. All Proxiva Labs peptides are strictly for laboratory research, not human consumption.
How long until results are visible?
Timelines vary by model and endpoint. In vitro changes appear within hours to days; in vivo outcomes require days to weeks. Chronic studies may extend months. Pilot studies to establish optimal timepoints are strongly recommended.
What is peptides for trigger finger?
Peptides for trigger finger encompasses a specific area of peptide science attracting significant research interest due to potential applications in biological research. Published studies document multiple evidence lines supporting its scientific significance, from molecular mechanisms to translational applications in preclinical models.
What mistakes should researchers avoid?
Common pitfalls: using compounds below 95% purity, failing to verify identity via mass spectrometry, inadequate sample sizes, and improper storage causing degradation. Always source from suppliers with verified purity documentation.
Related Research Resources
Explore more from Proxiva Labs:
- AOD 9604 — a modified GH fragment studied for lipolytic activity and fat metabolism
- Melanotan II — a synthetic melanocortin peptide studied for melanogenesis and photoprotection
- Tesamorelin — a GHRH analog studied for growth hormone release and visceral fat reduction
- Retatrutide — a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors
- GHK-Cu (Copper Peptide) — a copper-binding tripeptide studied for skin remodeling and gene expression modulation
- Browse All Research Guides
- Shop All Peptides
- Third-Party Test Results
Shop Research Peptides at Proxiva Labs
USA-Made • ?98% HPLC Purity • Third-Party Tested • Free Shipping $150+ • COA Included
a gastric pentadecapeptide studied for tissue repair and wound healing
a 43-amino acid peptide studied for tissue regeneration and anti-inflammatory ef
a synthetic melanocortin peptide studied for melanogenesis and photoprotection
a combination stack studied for synergistic tissue repair properties
a proprietary peptide blend studied for recovery and anti-inflammatory support
a modified GH fragment studied for lipolytic activity and fat metabolism
a synthetic ACTH analog studied for neuroprotective and cognitive effects
a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors